Literature DB >> 19925815

Validation of a total testosterone assay using high-turbulence liquid chromatography tandem mass spectrometry: total and free testosterone reference ranges.

Wael A Salameh1, Mildred M Redor-Goldman, Nigel J Clarke, Richard E Reitz, Michael P Caulfield.   

Abstract

Accurate measurement of testosterone concentration is of critical importance when diagnosing and treating male hypogonadism, congenital adrenal hyperplasia, premature or delayed puberty, and androgen excess in polycystic ovary syndrome or other virilizing conditions. However, some assays have inherent limitations and biases that affect measurement of low-testosterone values. Therefore, we developed a highly specific online mass spectrometry method. Sera were extracted online using high-turbulence flow liquid chromatography coupled to analytical HPLC and atmospheric pressure chemical ionization tandem mass spectrometry (HTLC-APCI-MS/MS). Analyte ions were monitored by multiple reaction monitoring (MRM). Total analysis time was 1.15 min per sample when using the multiplexing system. Testosterone concentrations were measured directly from 150 microL of serum or plasma without derivatization or liquid-liquid extraction. The lower limit of quantification was 0.3 ng/dL, and the assay was linear up to 2000 ng/dL. The method compared very well with an established RIA: y=1.02x+1.5, r(2)=0.994. Comparison with a platform immunoassay confirmed the previously reported ICMA positive bias at low concentrations. Male and female adult and pediatric reference ranges were developed for this very sensitive and accurate high-throughput LC-MS/MS method. This method is suitable for measuring the expected low-testosterone concentrations seen in women, children, and hypogonadal males and for monitoring testosterone suppressive therapy in prostate cancer patients. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19925815     DOI: 10.1016/j.steroids.2009.11.004

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  34 in total

1.  Biomarkers: Polycystic ovary syndrome: steroid assessment for diagnosis.

Authors:  Theresa E Hickey; Robert J Norman
Journal:  Nat Rev Endocrinol       Date:  2010-06       Impact factor: 43.330

2.  Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry.

Authors:  Micol S Rothman; Nichole E Carlson; Mei Xu; Christina Wang; Ronald Swerdloff; Paul Lee; Victor H H Goh; E Chester Ridgway; Margaret E Wierman
Journal:  Steroids       Date:  2010-11-09       Impact factor: 2.668

3.  Effect of Testosterone on FGF2, MRF4, and Myostatin in Hypogonadotropic Hypogonadism: Relevance to Muscle Growth.

Authors:  Husam Ghanim; Sandeep Dhindsa; Manav Batra; Kelly Green; Sanaa Abuaysheh; Nitesh D Kuhadiya; Antoine Makdissi; Ajay Chaudhuri; Paresh Dandona
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

4.  Green Tea Catechin Extract Supplementation Does Not Influence Circulating Sex Hormones and Insulin-Like Growth Factor Axis Proteins in a Randomized Controlled Trial of Postmenopausal Women at High Risk of Breast Cancer.

Authors:  Hamed Samavat; Anna H Wu; Giske Ursin; Carolyn J Torkelson; Renwei Wang; Mimi C Yu; Douglas Yee; Mindy S Kurzer; Jian-Min Yuan
Journal:  J Nutr       Date:  2019-04-01       Impact factor: 4.798

5.  Testosterone Increases the Expression and Phosphorylation of AMP Kinase α in Men With Hypogonadism and Type 2 Diabetes.

Authors:  Husam Ghanim; Sandeep Dhindsa; Manav Batra; Kelly Green; Sanaa Abuaysheh; Nitesh D Kuhadiya; Antoine Makdissi; Ajay Chaudhuri; Sartaj Sandhu; Paresh Dandona
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

Review 6.  Principles and clinical applications of liquid chromatography - tandem mass spectrometry for the determination of adrenal and gonadal steroid hormones.

Authors:  A E Kulle; M Welzel; P-M Holterhus; F G Riepe
Journal:  J Endocrinol Invest       Date:  2011-07-05       Impact factor: 4.256

7.  Adverse events associated with testosterone administration.

Authors:  Shehzad Basaria; Andrea D Coviello; Thomas G Travison; Thomas W Storer; Wildon R Farwell; Alan M Jette; Richard Eder; Sharon Tennstedt; Jagadish Ulloor; Anqi Zhang; Karen Choong; Kishore M Lakshman; Norman A Mazer; Renee Miciek; Joanne Krasnoff; Ayan Elmi; Philip E Knapp; Brad Brooks; Erica Appleman; Sheetal Aggarwal; Geeta Bhasin; Leif Hede-Brierley; Ashmeet Bhatia; Lauren Collins; Nathan LeBrasseur; Louis D Fiore; Shalender Bhasin
Journal:  N Engl J Med       Date:  2010-06-30       Impact factor: 91.245

8.  Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS).

Authors:  Eleftherios P Diamandis; Frank Z Stanczyk; Sarah Wheeler; Anu Mathew; Martin Stengelin; Galina Nikolenko; Eli N Glezer; Marshall D Brown; Yingye Zheng; Yen-Hao Chen; Hsiao-Li Wu; Ricardo Azziz
Journal:  Clin Chem Lab Med       Date:  2017-10-26       Impact factor: 3.694

9.  Effects of Testosterone Supplementation for 3 Years on Muscle Performance and Physical Function in Older Men.

Authors:  Thomas W Storer; Shehzad Basaria; Tinna Traustadottir; S Mitchell Harman; Karol Pencina; Zhuoying Li; Thomas G Travison; Renee Miciek; Panayiotis Tsitouras; Kathleen Hally; Grace Huang; Shalender Bhasin
Journal:  J Clin Endocrinol Metab       Date:  2017-02-01       Impact factor: 5.958

10.  Revisiting hyper- and hypo-androgenism by tandem mass spectrometry.

Authors:  Flaminia Fanelli; Alessandra Gambineri; Marco Mezzullo; Valentina Vicennati; Carla Pelusi; Renato Pasquali; Uberto Pagotto
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.